A1RG34.SA

argenx SE · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$49.49B

PE Ratio

224.56

EV to Ebitda

—

Earnings Yield

0.00%

Revenue (TTM)

$840.9M

Net Income (TTM)

$220.3M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

73.00%

Profit Margin

30.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core5 fields›

Market Cap$49.49B

Revenue TTM$840.9M

Shares Outstanding1.55B

Insider Ownership0.00%

Institutional Ownership0.00%

Growth Estimates4 fields›

Revenue Growth (Quarterly YoY)73.00%

Rev Growth Est 1Y Forward0.2

EPS Growth (Quarterly YoY)-32.00%

EPS Growth Est Quarterly0

Operations18 fields›

Revenue TTM$840.9M

Gross Margin TTM57.00%

Gross Margin (Quarterly)89.00%

Operating Margin TTM27.00%

Operating Margin (Quarterly)25.00%

Operating Expenses TTM$4.2M

Profit Margin TTM30.00%

Profit Margin (Quarterly)11.00%

Net Income TTM$220.3M

EPS TTM3.87

EPS (Quarterly)0.29

EBITDA Margin TTM25.00%

EBITDA TTM$210.8M

CFO TTM$29.3M

Capex % of Revenue TTM1.00%

Capital Expenditures$9.7M

FCF % of Revenue (Quarterly)14.00%

FCF TTM$0.00M

Efficiency1 fields›

ROA9.00%

Valuation8 fields›

P/E (TTM)224.56

P/E Forward29.85

PEG1.27

EV/Revenues (TTM)10.96

Price To Book34.03

Price to Tangible Book34.03

Earnings Yield0.00%

Payout Ratio0.00%

Liquidity6 fields›

Current Ratio5.23

Cash & ST Assets$3.49B

Total Assets$1.72B

Total Liabilities$730.1M

Shareholders Equity$1.45B

Interest Expense$4.2M

Yields2 fields›

Payout Ratio0.00%

Earnings Yield0.00%